616 related articles for article (PubMed ID: 21716259)
1. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis.
Chen YT; Chang FC; Wu CF; Chou YH; Hsu HL; Chiang WC; Shen J; Chen YM; Wu KD; Tsai TJ; Duffield JS; Lin SL
Kidney Int; 2011 Dec; 80(11):1170-81. PubMed ID: 21716259
[TBL] [Abstract][Full Text] [Related]
2. Blockade of PDGF receptor signaling reduces myofibroblast number and attenuates renal fibrosis.
LeBleu VS; Kalluri R
Kidney Int; 2011 Dec; 80(11):1119-21. PubMed ID: 22083636
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.
Wu CF; Chiang WC; Lai CF; Chang FC; Chen YT; Chou YH; Wu TH; Linn GR; Ling H; Wu KD; Tsai TJ; Chen YM; Duffield JS; Lin SL
Am J Pathol; 2013 Jan; 182(1):118-31. PubMed ID: 23142380
[TBL] [Abstract][Full Text] [Related]
4. Exogenous bone marrow derived-putative endothelial progenitor cells attenuate ischemia reperfusion-induced vascular injury and renal fibrosis in mice dependent on pericytes.
Wang M; Xu H; Li Y; Cao C; Zhu H; Wang Y; Zhao Z; Pei G; Zhu F; Yang Q; Deng X; Zhou C; Guo Y; Wu J; Liao W; Yang J; Yao Y; Zeng R
Theranostics; 2020; 10(26):12144-12157. PubMed ID: 33204334
[No Abstract] [Full Text] [Related]
5. Novel insights into pericyte-myofibroblast transition and therapeutic targets in renal fibrosis.
Chang FC; Chou YH; Chen YT; Lin SL
J Formos Med Assoc; 2012 Nov; 111(11):589-98. PubMed ID: 23217594
[TBL] [Abstract][Full Text] [Related]
6. Putative endothelial progenitor cells do not promote vascular repair but attenuate pericyte-myofibroblast transition in UUO-induced renal fibrosis.
Yang J; Wang M; Zhu F; Sun J; Xu H; Chong Lee Shin OL; Zhao Z; Pei G; Zhu H; Cao C; He X; Huang Y; Ma Z; Liu L; Wang L; Ning Y; Liu W; Xu G; Wang X; Zeng R; Yao Y
Stem Cell Res Ther; 2019 Mar; 10(1):104. PubMed ID: 30898157
[TBL] [Abstract][Full Text] [Related]
7. Notch1 promotes the pericyte-myofibroblast transition in idiopathic pulmonary fibrosis through the PDGFR/ROCK1 signal pathway.
Wang YC; Chen Q; Luo JM; Nie J; Meng QH; Shuai W; Xie H; Xia JM; Wang H
Exp Mol Med; 2019 Mar; 51(3):1-11. PubMed ID: 30902967
[TBL] [Abstract][Full Text] [Related]
8. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1.
Ren S; Johnson BG; Kida Y; Ip C; Davidson KC; Lin SL; Kobayashi A; Lang RA; Hadjantonakis AK; Moon RT; Duffield JS
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1440-5. PubMed ID: 23302695
[TBL] [Abstract][Full Text] [Related]
9. Wnt4/β-catenin signaling in medullary kidney myofibroblasts.
DiRocco DP; Kobayashi A; Taketo MM; McMahon AP; Humphreys BD
J Am Soc Nephrol; 2013 Sep; 24(9):1399-412. PubMed ID: 23766539
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis.
Martin IV; Borkham-Kamphorst E; Zok S; van Roeyen CR; Eriksson U; Boor P; Hittatiya K; Fischer HP; Wasmuth HE; Weiskirchen R; Eitner F; Floege J; Ostendorf T
Am J Pathol; 2013 Jan; 182(1):107-17. PubMed ID: 23141925
[TBL] [Abstract][Full Text] [Related]
11. Novel Mechanism of the Pericyte-Myofibroblast Transition in Renal Interstitial Fibrosis: Core Fucosylation Regulation.
Wang N; Deng Y; Liu A; Shen N; Wang W; Du X; Tang Q; Li S; Odeh Z; Wu T; Lin H
Sci Rep; 2017 Dec; 7(1):16914. PubMed ID: 29209018
[TBL] [Abstract][Full Text] [Related]
12. Renal ischemia-reperfusion induces a dysbalance of angiopoietins, accompanied by proliferation of pericytes and fibrosis.
Khairoun M; van der Pol P; de Vries DK; Lievers E; Schlagwein N; de Boer HC; Bajema IM; Rotmans JI; van Zonneveld AJ; Rabelink TJ; van Kooten C; Reinders ME
Am J Physiol Renal Physiol; 2013 Sep; 305(6):F901-10. PubMed ID: 23825073
[TBL] [Abstract][Full Text] [Related]
13. Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation.
Bijkerk R; de Bruin RG; van Solingen C; van Gils JM; Duijs JM; van der Veer EP; Rabelink TJ; Humphreys BD; van Zonneveld AJ
Kidney Int; 2016 Jun; 89(6):1268-80. PubMed ID: 27165825
[TBL] [Abstract][Full Text] [Related]
14. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
[TBL] [Abstract][Full Text] [Related]
15. The proto-oncogene tyrosine protein kinase Src is essential for macrophage-myofibroblast transition during renal scarring.
Tang PM; Zhou S; Li CJ; Liao J; Xiao J; Wang QM; Lian GY; Li J; Huang XR; To KF; Ng CF; Chong CC; Ma RC; Lee TL; Lan HY
Kidney Int; 2018 Jan; 93(1):173-187. PubMed ID: 29042082
[TBL] [Abstract][Full Text] [Related]
16. The intrinsic prostaglandin E2-EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice.
Nakagawa N; Yuhki K; Kawabe J; Fujino T; Takahata O; Kabara M; Abe K; Kojima F; Kashiwagi H; Hasebe N; Kikuchi K; Sugimoto Y; Narumiya S; Ushikubi F
Kidney Int; 2012 Jul; 82(2):158-71. PubMed ID: 22513820
[TBL] [Abstract][Full Text] [Related]
17. Role of PDGFs/PDGFRs signaling pathway in myocardial fibrosis of DOCA/salt hypertensive rats.
Fan B; Ma L; Li Q; Wang L; Zhou J; Wu J
Int J Clin Exp Pathol; 2014; 7(1):16-27. PubMed ID: 24427322
[TBL] [Abstract][Full Text] [Related]
18. [The effect of transforming growth factor β(1) in the transition of bone marrow-derived macrophages into myofibroblasts during renal fibrosis].
Yang Y; Feng XJ; Liu XY; Wang LH; Zheng GP
Zhonghua Nei Ke Za Zhi; 2017 Aug; 56(8):610-613. PubMed ID: 28789496
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of fibrosis: the role of the pericyte.
Schrimpf C; Duffield JS
Curr Opin Nephrol Hypertens; 2011 May; 20(3):297-305. PubMed ID: 21422927
[TBL] [Abstract][Full Text] [Related]
20. [Pathomechanisms of pericyte-myofibroblast transition in kidney and interventional effects of Chinese herbal medicine].
Liu YL; Shi G; Cao DW; Wan YG; Wu W; Tu Y; Liu BH; Han WB; Yao J
Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4192-4197. PubMed ID: 30583616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
